Ansell Limited (ASX:ANN)
Australia · Delayed Price · Currency is AUD | Market Cap | 3.64B -20.9% |
| Revenue (ttm) | 3.01B +8.4% |
| Net Income | 202.99M +20.8% |
| EPS | 1.39 +15.5% |
| Shares Out | 139.63M |
| PE Ratio | 18.73 |
| Forward PE | 12.51 |
| Dividend | 0.79 (3.01%) |
| Ex-Dividend Date | Feb 23, 2026 |
| Volume | 368,578 |
| Average Volume | 426,955 |
| Open | 26.10 |
| Previous Close | 26.09 |
| Day's Range | 26.09 - 26.43 |
| 52-Week Range | 25.05 - 37.54 |
| Beta | 0.55 |
| RSI | 47.35 |
| Earnings Date | Aug 24, 2026 |
About Ansell
Ansell Limited designs, sources, develops, manufactures, distributes, and sells hand and body protection solutions in the Asia Pacific, Europe, the Middle East, Africa, Latin America, the Caribbean, and North America. It operates through two segments: Healthcare and Industrial. The Healthcare segment manufactures and markets solutions, including surgical gloves, single-use and examination gloves, and clean and sterile gloves and garments, as well as consumables for hospitals, surgical centers, dental surgeries, veterinary clinics, first respond... [Read more]
Financial Performance
In fiscal year 2025, Ansell's revenue was $2.00 billion, an increase of 23.71% compared to the previous year's $1.62 billion. Earnings were $101.60 million, an increase of 32.81%.
Financial numbers in USD Financial StatementsNews
Ansell Earnings Call Transcript: H1 2026
Double-digit adjusted EPS growth and record cash flow were achieved despite subdued markets, with tariff costs fully offset by price increases and productivity gains. Guidance is maintained, supported by innovation, strong balance sheet, and ongoing share buybacks.
Ansell Quarterly report: H1 2026
Ansell has published its H1 2026 quarterly earnings report on February 15, 2026.
Ansell Slides: H1 2026
Ansell has posted slides in relation to its H1 2026 quarterly earnings report, which was published on February 15, 2026.
Ansell Transcript: AGM 2025
Strong FY2025 results were driven by organic growth, successful KBU integration, and productivity gains. The board addressed U.S. tariff risks, labor rights, and sustainability, with ongoing board succession and digital transformation initiatives.
Ansell Slides: FY 2025
Ansell has posted slides in relation to its FY 2025 quarterly earnings report, which was published on October 28, 2025.
Ansell Earnings Call Transcript: H2 2025
Delivered strong FY 2025 results with 8% organic sales growth, 10% EBIT growth, and adjusted EPS at the top end of guidance. KBU integration exceeded expectations, and a $200M share buyback is planned. FY 2026 guidance anticipates further growth and tariff mitigation.
Ansell Annual report: H2 2025
Ansell has published its H2 2025 annual report on August 24, 2025.
Ansell Slides: H2 2025
Ansell has posted slides in relation to its H2 2025 quarterly earnings report, which was published on August 24, 2025.
Ansell initiated with an Equal Weight at Morgan Stanley
Morgan Stanley analyst David Bailey initiated coverage of Ansell (ANSLF) with an Equal Weight rating and A$37.20 price target The Kimberley Clarke PPE acquisition is expected to provide “solid EPS…
Ansell (ANN) Shares Soar on Upbeat FY25 Growth Forecast
Shares of the ASX-listed Ansell Limited ($AU:ANN) soared nearly 9%, fueled by the company’s upbeat organic growth forecast for FY25. The company announced its FY24 annual results, noting that post-pan...
PPE Manufacturer Ansell Still Trading at a Nice Valuation
Imagine investing in a company that made rubber gloves, facemasks and Hazmat suits during the Covid-19 pandemic. It exists!